Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Scheel

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Histology and Histopathology|March 26, 2024
Upregulation and epigenetic modification of the creatine transporter SLC6A8 in non-small cell lung cancerChristiane Kuempers, Karoline Schnepf, Sebastian Marwitz, et al.
Viruses|September 28, 2023
Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 PatientsThilo Gambichler, Nadine Schuleit, Laura Susok, et al.
Nature Communications|January 29, 2022
Transcriptional changes in the mammary gland during lactation revealed by single cell sequencing of cells from human milkAlecia-Jane Twigger, Lisa K Engelbrecht, Karsten Bach, et al.
Journal of Virology|December 3, 2010
Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralizationJannick Prentoe, Tanja B Jensen, Philip Meuleman, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2013
Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a virusesJudith M Gottwein, Sanne B Jensen, Yi-Ping Li, et al.
Journal of Virology|December 24, 2010
Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutationsTroels K H Scheel, Judith M Gottwein, Thomas H R Carlsen, et al.
Gastroenterology|December 25, 2017
Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape VariantsJudith M Gottwein, Long V Pham, Lotte S Mikkelsen, et al.
Journal of Virology|March 31, 2026
Development of a Norway rat hepacivirus reporter for high-throughput quantification of neutralizing antibodiesMatthew J Kennedy, Raphael Wolfisberg, Emma A Lundsgaard, et al.
Cell Reports|March 24, 2023
Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infectionNicolas Fossat, Emma A Lundsgaard, Rui Costa, et al.
Nature Communications|July 19, 2023
Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington's diseaseMeeli Mullari, Nicolas Fossat, Niels H Skotte, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Histology and Histopathology|March 26, 2024
Upregulation and epigenetic modification of the creatine transporter SLC6A8 in non-small cell lung cancerChristiane Kuempers, Karoline Schnepf, Sebastian Marwitz, et al.
Viruses|September 28, 2023
Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 PatientsThilo Gambichler, Nadine Schuleit, Laura Susok, et al.
Nature Communications|January 29, 2022
Transcriptional changes in the mammary gland during lactation revealed by single cell sequencing of cells from human milkAlecia-Jane Twigger, Lisa K Engelbrecht, Karsten Bach, et al.
Journal of Virology|December 3, 2010
Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralizationJannick Prentoe, Tanja B Jensen, Philip Meuleman, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2013
Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a virusesJudith M Gottwein, Sanne B Jensen, Yi-Ping Li, et al.
Journal of Virology|December 24, 2010
Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutationsTroels K H Scheel, Judith M Gottwein, Thomas H R Carlsen, et al.
Gastroenterology|December 25, 2017
Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape VariantsJudith M Gottwein, Long V Pham, Lotte S Mikkelsen, et al.
Journal of Virology|March 31, 2026
Development of a Norway rat hepacivirus reporter for high-throughput quantification of neutralizing antibodiesMatthew J Kennedy, Raphael Wolfisberg, Emma A Lundsgaard, et al.
Cell Reports|March 24, 2023
Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infectionNicolas Fossat, Emma A Lundsgaard, Rui Costa, et al.
Nature Communications|July 19, 2023
Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington's diseaseMeeli Mullari, Nicolas Fossat, Niels H Skotte, et al.
Pageof 17